ArticlePLoS neglected tropical diseases2025
Demographic, temporal, and spatial analysis of human animal bite cases in Mymensingh District, Bangladesh.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nationwide registry-based analysis of rabies exposures in Iran: Epidemiological patterns and post-exposure prophylaxis adherence.PLoS neglected tropical diseases · 2026Article
- Two-leaves and many bites: Profiling dog-bites and adherence to rabies prophylaxis in tea-estate communities of Udalguri District, Assam, India.PLoS neglected tropical diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to analyze the demographic, temporal, and spatial characteristics of animal bite (AB) cases in humans across 12 Upazilas within Mymensingh district of Bangladesh.
methodsRetrospective hospital-based data from individual AB cases for 2022 and 2023 were collected from S.K Hospital. The dataset included information on victim demographics, bite details, vaccination information, and Rabies Immune Globulin (RIG) administration. Additionally, monthly case counts from 2016 to 2024 were sourced and analyzed to identify trends. Descriptive statistics and time series analysis using the seasonal decomposition technique were conducted. Risk maps for animal bites in 2022 and 2023 were generated using a standardized incidence ratio (SIR) approach.
findingsAn almost two-fold increase in the proportion of category 3 bites receiving RIG from 3.6% in 2022 to 6.5% in 2023 was noted. Only 9.7% (2022) and 16.9% (2023) of bite victims received PEP on the day of exposure, whereas 76.5% (2022) and 84.6% (2023) received PEP within 24 hours. Moreover, significant seasonal patterns and annual increasing trends in AB cases were observed. Males and children under 14 years old had a higher risk of being bitten. Dogs (48.2% in 2022) and cats (52.6% in 2023) were identified as the primary animals responsible for the bites. Notably, the legs were the body part most frequently bitten. The bites risk map identified four high risk Upazilas.
conclusionDespite improvements in PEP coverage achieved within 24 hours, a critical gap remains in same-day PEP coverage in both years. The study results also suggest other potential improvements in healthcare practices or treatment protocols, and the need for a veterinary surveillance system. Increasing AB cases highlight the need to enhance surveillance and control measures. Targeted awareness campaigns tailored to high-risk groups such as males and children under 14 years of age, along with preventive programs focused on dogs are imperative. Coordinated One Health efforts among healthcare professionals, veterinarians, policymakers, and community stakeholders are crucial to effectively mitigate the incidence of AB cases, safeguarding public health and eliminate dog mediated rabies by 2030 in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.